BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12840862)

  • 1. Quantitative study on expression of p16 multiple tumor suppressor gene in salivary gland neoplasm.
    Zhu S; Wang X; Shao L; Chen W; Chen X; Wu H
    J Tongji Med Univ; 1999; 19(2):155-7. PubMed ID: 12840862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of p16 and nm23 genes in salivary gland tumors].
    Gong L; Chen ZL; Hu J; Huo HY
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Apr; 22(2):155-7. PubMed ID: 15190803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency of p16 and p14 promoter hypermethylation and marked telomere instability in salivary gland tumors.
    Nikolic N; Anicic B; Carkic J; Simonovic J; Toljic B; Tanic N; Tepavcevic Z; Vukadinovic M; Konstantinovic VS; Milasin J
    Arch Oral Biol; 2015 Nov; 60(11):1662-6. PubMed ID: 26351750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A qualititative study on p16 mutiple tumor suppressor gene, ras oncogene p21 and DNA content in parotid tumor and its' contiguous acini].
    Zhu S; Wang X; Shao L
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 Sep; 36(5):361-3. PubMed ID: 11769651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of the INK4a-ARF gene locus in pleomorphic adenoma of the parotid gland.
    Weber A; Langhanki L; Schütz A; Wittekind C; Bootz F; Tannapfel A
    J Pathol; 2002 Nov; 198(3):326-34. PubMed ID: 12375265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant protein expression and promoter methylation of p16 gene are correlated with malignant transformation of salivary pleomorphic adenoma.
    Hu YH; Zhang CY; Tian Z; Wang LZ; Li J
    Arch Pathol Lab Med; 2011 Jul; 135(7):882-9. PubMed ID: 21732778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of p16 in pleomorphic salivary adenoma.
    Tarakji B; Baroudi K; Darwish S; Sakka S; Hanouneh S
    Turk Patoloji Derg; 2013; 29(1):36-40. PubMed ID: 23354794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of inverse correlation of p16 and pRb expression in carcinoma ex pleomorphic adenoma.
    Tarakji B; Alenzi F; Al-Khuraif AA
    Pol J Pathol; 2013 Jun; 64(2):144-8. PubMed ID: 23900873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of p16(INK4A) and cyclin D1 in benign and malignant salivary gland tumors: a study of 44 Cases.
    Jour G; West K; Ghali V; Shank D; Ephrem G; Wenig BM
    Head Neck Pathol; 2013 Sep; 7(3):224-31. PubMed ID: 23315417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin D1 and p16 expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma of the parotid gland.
    Patel RS; Rose B; Bawdon H; Hong A; Lee CS; Fredericks S; Gao K; O'Brien CJ
    Histopathology; 2007 Nov; 51(5):691-6. PubMed ID: 17927591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of the p16 gene and microsatellite instability in carcinoma arising in pleomorphic adenoma of the parotid gland.
    Suzuki H; Fujioka Y
    Diagn Mol Pathol; 1998 Aug; 7(4):224-31. PubMed ID: 9917133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quantitative studies of oncogene ras P21 and P53 gene protein expression in the benign and malignant pleomorphic adenomas of salivary gland].
    Wang J; Dong F; Wang X
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1997 Jul; 32(4):208-11. PubMed ID: 10680505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of p63 isotypes (DeltaN and TA) in salivary gland neoplasms: biological and diagnostic implications.
    Maruya S; Kies MS; Williams M; Myers JN; Weber RS; Batsakis JG; El-Naggar AK
    Hum Pathol; 2005 Jul; 36(7):821-7. PubMed ID: 16084953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoma ex pleomorphic adenoma: A diagnostic challenge on cytology.
    Singh K; Agarwal C; Pujani M; Verma P; Chauhan V
    Diagn Cytopathol; 2017 Jul; 45(7):651-654. PubMed ID: 28261993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Nrf2 in pathology of pleomorphic adenoma in parotid gland.
    Droździk A; Kowalczyk R; Jaworowska E; Urasińska E; Kurzawski M
    Med Sci Monit; 2015 Apr; 21():1243-8. PubMed ID: 25928388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
    Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
    Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors.
    Queimado L; Lopes CS; Reis AM
    Genes Chromosomes Cancer; 2007 Mar; 46(3):215-25. PubMed ID: 17171686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of new genes of pleomorphic adenoma.
    Choi JS; Cho BH; Kim HJ; Kim YM; Jang JH
    Medicine (Baltimore); 2019 Dec; 98(51):e18468. PubMed ID: 31861025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between c-erbB-2 oncoprotein expression and prognosis in salivary gland malignant pleomorphic adenoma].
    Yan Y; Guo Q; Nan P
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1995 Nov; 30(6):326-8, 383. PubMed ID: 8762532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the tumour suppressor genes, FHIT and WT-1, and the tumour rejection genes, BAGE, GAGE-1/2, HAGE, MAGE-1, and MAGE-3, in benign and malignant neoplasms of the salivary glands.
    Nagel H; Laskawi R; Eiffert H; Schlott T
    Mol Pathol; 2003 Aug; 56(4):226-31. PubMed ID: 12890744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.